04/25/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
04/23/2024 5:06 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024 3:31 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
04/18/2024 1:33 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC 13D | |
04/17/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
04/16/2024 4:07 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
04/15/2024 2:44 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
|
04/11/2024 5:01 AM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T | |
02/15/2024 3:15 PM | Novartis (Filer)
| Form S-8 POS | |
02/06/2024 3:52 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-C | |
02/05/2024 4:06 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-C | |
02/02/2024 1:18 PM | BlackRock Inc. (Filed by) Novartis (Subject)
| Form SC 13G/A | |
01/31/2024 6:43 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024 6:43 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024 6:44 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024 6:44 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024 6:38 AM | Novartis (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
01/31/2024 6:42 AM | Novartis (Filer)
| Form IRANNOTICE | |
01/08/2024 5:13 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2023 5:05 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2023 7:19 PM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/28/2023 5:10 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2023 5:05 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/24/2023 5:33 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2023 5:57 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2023 5:05 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2023 5:10 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/21/2023 5:05 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/09/2023 5:05 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/18/2023 6:30 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/10/2023 3:08 PM | CHINOOK THERAPEUTICS, INC. (Subject) CHINOOK THERAPEUTICS, INC. (Subject) Novartis (Filed by)
| Form DFAN14A | |
07/10/2023 5:06 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2023 8:26 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2023 8:41 AM | CHINOOK THERAPEUTICS, INC. (Subject) CHINOOK THERAPEUTICS, INC. (Subject) Novartis (Filed by)
| Form DFAN14A | |